Orion’s milestones in the 2000s

2003: Stalevo, a drug developed and patented by Orion for the treatment of Parkinson’s disease, is authorised for marketing.

2005: Generic drugs become Orion’s focus area, along with proprietary drugs.

2006: Orion successfully focuses on its core operations: drug production and diagnostics.